Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Volt Pharma Associates

VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group logo

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Market access, Regulatory affairs, Research and development

Company Details

Volt Pharma Associates
Engesserstrasse 4B, Freiburg, 79114, Germany
+49 172 6340202
Contact Volt Pharma Associates
Website

 Latest Content from PMHub 

2018 was a magical year for Lucid Group, filled with memorable moments and many celebrations

Press Releases | December 18, 2018 | Lucid Group Communications Limited

This year has been a ground-breaking year for Lucid Group, punctuated by magical makeovers, plenty of awards, landmark staff celebrations and worthwhile charity work.The tone of the year was set...

We’ve moved!

Press Releases | December 14, 2018 | Blue Latitude Health

Blue Latitude Health has moved office to a new location in Barbican, Central London, following a year of substantial growth.

New editor adds microscopic attention to detail at Porterhouse Medical

Press Releases | December 13, 2018 | Porterhouse Medical Group

The Porterhouse Medical Group is delighted to welcome Isabel Thomas to our scientific services team in Reading.Joining us as an associate editor, Isabel will be working closely alongside Stephanie, senior editor, to boost...

Navigating the antibiotic resistance crisis

White Papers and Resources | December 13, 2018 | Blue Latitude Health

Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Blue Latitude Health joins Fishawack Group of Companies

Press Releases | December 12, 2018 | Blue Latitude Health

Blue Latitude Health announces a new partnership with Fishawack Group of Companies, fuelling our global growth.

Healthcare excellence celebrated at 2018 HSJ Awards

Press Releases | December 11, 2018 | Wilmington Healthcare

Thousands of healthcare professionals were in attendance, all eager to scoop one of the coveted prizes from the world’s largest healthcare awards programme.

Report: Achieving launch excellence in the challenging healthcare markets of today

White Papers and Resources | December 10, 2018 | Blue Latitude Health

Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...

NHS medicines optimisation milestone

White Papers and Resources | December 10, 2018 | Wilmington Healthcare

Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry

What is blockchain and why should i care – Richard Springham

White Papers and Resources | December 9, 2018 | Four Agency Worldwide

Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...

Lucid Group celebrate another magical year at their Winter Meeting

Press Releases | December 7, 2018 | Lucid Group Communications Limited

2018 has without doubt been a stellar year for Lucid Group, scooping a double win at Communiqué - winning both Communiqué Medical Education Consultancy of the Year and Communiqué Communications...